Bone morphogenetic protein 1: a prognostic indicator and potential biomarker in three cancer types
CONCLUSION: In conclusion, our study has provided some solid basis for BMP1 to be used as a reliable common biomarker for BLCA, KIRC, and LUAD patients.PMID:38463598 | PMC:PMC10918118 | DOI:10.62347/PWZA6242
Source: American Journal of Translational Research - Category: Research Authors: Ming Wang Chunmei Liu Yingjie Wang Muhammad Jamil Majid Alhomrani Abdulhakeem S Alamri Walaa F Alsanie Abdulaziz Alsharif Mubarik Ali Norina Jabeen Source Type: research
More News: Adenocarcinoma | Amoebiasis | Bladder Cancer | Cancer | Cancer & Oncology | Carcinoma | Clear Cell Carcinoma | Databases & Libraries | Genetics | Research | Study | Urology & Nephrology